Day: June 2, 2025

Matthew Hayden transitions to new strategic role; Dan Torpey appointed Audit Committee Chair Addison, TX, June 02, 2025 (GLOBE NEWSWIRE) — MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading disruptive technology companies, today announced key leadership transitions within its Board of Directors. Matthew Hayden, a board director since July 2022, will step down effective June 30, 2025, to assume a newly created role as Entrepreneur in Residence. In this position, Mr. Hayden will continue to support MDB’s mission by applying his three decades of experience as an operator, investor, and strategic advisor to help guide early-stage disruptive technology companies through launch and growth while significantly expanding the firm’s public venture community. “Matt has been an...

SAN JOSE, Calif., June 02, 2025 (GLOBE NEWSWIRE) — Adeia Inc. (Nasdaq: ADEA), a leader in developing innovative technology solutions, announced today that Keith A. Jones, chief financial officer, has been invited to present at the “2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow,” presented by Maxim Group LLC, on Tuesday, June 3rd – Thursday, June 5th at 9:00 a.m. EDT. Adeia’s fireside chat will be Wednesday, June 4th at 4:00 p.m. EDT. Click here to learn more and reserve your seat Adeia will be taking part in the “2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow.” The rapid evolution of technology is paving the way for disruption across all industries, including healthcare, drones, consumer IoT, business solutions, gaming & entertainment, and more. In Maxim’s 2025 Virtual...

HOLLISTON, Mass., June 02, 2025 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the appointment of John Duke to its board of directors, effective June 2, 2025. Mr. Duke will also serve on the audit and nominating and governance committees. The Company also announced that Katherine Eade has been named Lead Independent Director of the Company’s board of directors. “We are pleased to welcome John to Harvard Bioscience’s board,” said Katherine Eade, Lead Independent Director. “John brings deep experience in life science tools and business execution and has a track record of driving growth and operational excellence.” Jim Green, President and CEO, said, “The combination of John’s operating experience along with his strong technical and business background make John an excellent addition to...

ROCHESTER, N.Y., June 02, 2025 (GLOBE NEWSWIRE) — Constellation Brands (NYSE: STZ), a leading beverage alcohol company, announced today that it has given notice for full redemption prior to maturity of all of its outstanding 4.75% Senior Notes due 2025 (CUSIP Number: 21036PAP3) and 5.00% Senior Notes due 2026 (CUSIP Number: 21036PBN7) (collectively, the ”notes”) to be effected on July 2, 2025 and June 12, 2025, respectively. As of June 2, 2025, there were $900.0 million in aggregate principal amount of the notes outstanding. The redemption price for the notes, payable in cash, will be calculated pursuant to the formula set forth in the supplemental indentures relating to the notes. This press release shall not constitute a notice of redemption of the notes. Information concerning the terms and conditions of the redemption of the...

TORONTO, June 02, 2025 (GLOBE NEWSWIRE) — Altai Resources Inc. (TSXV: ATI) (“Altai” or the “Company”) announced today that the Company has completed the repositioning of its Canadian investment portfolio (the “Investment Portfolio”) through the sale of all marketable securities and the subsequent reinvestment of those net cash proceeds into cash and cash equivalents (the “Repositioning”), to maximize the liquidity of the Investment Portfolio and to eliminate any associated equity market risk. As a result of the Repositioning, the Company’s Investment Portfolio is now comprised of cash and cash equivalents, with a total market value of approximately $3.9 million. Based on the Company’s total issued and outstanding common shares of 56,033,552 as of May 30, 2025 (the “Common Shares”), the market value of the Investment Portfolio per...

Retained portfolio for Constellation includes a collection of award-winning, iconic brands, predominantly priced $15 and above and in growing segments and channels ROCHESTER, N.Y., June 02, 2025 (GLOBE NEWSWIRE) — Constellation Brands (NYSE: STZ), a leading beverage alcohol company, announced today that it has closed its previously announced transaction with The Wine Group to divest1 primarily mainstream wine brands and associated inventory, facilities, and vineyards from its wine portfolio. Brands divested to The Wine Group include Woodbridge, Meiomi, Robert Mondavi Private Selection, Cook’s, SIMI, and J. Rogét sparkling wine. Constellation’s retained wine portfolio consists of a collection of highly regarded wines from top regions around the world, predominantly priced $15 and above. This includes iconic Napa Valley brands Robert...

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) — 21Shares US LLC (“21Shares”), an affiliate of 21Shares AG, one of the world’s largest issuers of crypto exchange traded funds (“ETFs”), today announced a 3-for-1 share split for its flagship fund ARK 21Shares Bitcoin ETF (ARKB). This move is designed to make shares more accessible to a broader base of investors and enhance trading efficiency. The share split is expected to be effective at market open on June 16, 2025. Following the split, the fund’s shares will continue to trade under the ticker symbol “ARKB” under the same CUSIP, and the total net asset value (NAV) of ARKB will not change as a result of the split. The investment objective, strategy, and underlying holdings of the fund remain unchanged.Fund name Ticker CUSIP SplitRatio RecordDate Pay Date Ex-DateARK 21SharesBitcoin...